It has been clinically proven the gastrointestinal surgeries (i.e. gastric bypass, sleeve gastrectomy), has a near instant positive impact on obese patients with comorbidities such as Type II Diabetes, Hypertension, etc. Many patients are able to discontinue use of drugs for these conditions within a week or two. This SAVES lives and in the long run by reducing costs for medications, should impact the cost of insurance.
Dear Health Insurance Providers and Patients,
It has been clinically proven the gastrointestinal surgeries (i.e. gastric bypass, sleeve gastrectomy), has a near instant positive impact on obese patients with comorbidities such as Type II Diabetes, Hypertension, etc. Many patients are able to discontinue use of drugs for these conditions within a week or two. This SAVES lives and in the long run by reducing costs for medications, should impact the cost of insurance.